REPRELLA Trademark

Trademark Overview

On Monday, July 28, 2014, a trademark application was filed for REPRELLA with the United States Patent and Trademark Office. The USPTO has given the REPRELLA trademark a serial number of 86349746. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 26, 2018. This trademark is owned by Glaxo Group Limited. The REPRELLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
reprella

General Information

Serial Number86349746
Word MarkREPRELLA
Filing DateMonday, July 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, March 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2017EXTENSION 5 GRANTED
Friday, August 4, 2017EXTENSION 5 FILED
Friday, August 4, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2017EXTENSION 4 GRANTED
Wednesday, February 8, 2017EXTENSION 4 FILED
Wednesday, February 8, 2017TEAS EXTENSION RECEIVED
Monday, January 30, 2017ASSIGNED TO EXAMINER
Thursday, August 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2016EXTENSION 3 GRANTED
Wednesday, July 27, 2016EXTENSION 3 FILED
Wednesday, July 27, 2016TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2016EXTENSION 2 GRANTED
Thursday, February 11, 2016EXTENSION 2 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Thursday, July 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 30, 2015EXTENSION 1 GRANTED
Tuesday, June 30, 2015EXTENSION 1 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 31, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

reprella pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological